Brevibloc Interactions
There are 402 drugs known to interact with Brevibloc (esmolol), along with 16 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 27 are major, 356 are moderate, and 19 are minor.
- View all 402 medications that may interact with Brevibloc
- View Brevibloc alcohol/food interactions (1)
- View Brevibloc disease interactions (16)
Most frequently checked interactions
View interaction reports for Brevibloc (esmolol) and the medicines listed below.
- adenosine
- Adriamycin (doxorubicin)
- Advate (antihemophilic factor)
- albuterol
- amiodarone
- ampicillin
- atropine
- calcium chloride
- Cardizem (diltiazem)
- Diacomit (stiripentol)
- diltiazem
- diphenhydramine
- Diprivan (propofol)
- dobutamine
- dopamine
- enalapril
- epinephrine
- etomidate
- fentanyl
- flumazenil
- heparin
- Kalydeco (ivacaftor)
- lidocaine
- Meticorten (prednisone)
- metoprolol
- midazolam
- moxifloxacin
- naloxone
- terbutaline
- vasopressin
Brevibloc alcohol/food interactions
There is 1 alcohol/food interaction with Brevibloc (esmolol).
Brevibloc disease interactions
There are 16 disease interactions with Brevibloc (esmolol) which include:
- bradyarrhythmia/AV block
- cardiogenic shock/hypotension
- CHF
- diabetes
- hypersensitivity
- ischemic heart disease
- PVD
- cerebrovascular insufficiency
- glaucoma
- hyperthyroidism
- myasthenia gravis
- pheochromocytoma
- psoriasis
- tachycardia
- asthma/COPD
- renal dysfunction
Report options
QR code containing a link to this page
More about Brevibloc (esmolol)
- Brevibloc consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: cardioselective beta blockers
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
